Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.
Deepak Shenoy of Capitalmind.in likes Strides Arcolab for the long term.
Deepak Shenoy, Founder of Capitalmind.in likes Sun Pharma and Strides Arcolab and feels that pharma as a space is worth looking into.
Sudarshan Sukhani of s2analytics.com recommends buying Lupin and Shasun Pharmaceuticals.
According to Pritesh Mehta of IIFL, one can buy Shasun Pharma as the stock may test Rs 370.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Maruti Suzuki, Eicher Motor, BEML, HCC, Sun Pharma, IL&FS Engg, Hathway Cables, Glenmark Pharma & ITDC.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Wockhardt, United Spirits, ABG Shipyard, Ballarpur Industries, ITDC & Sun Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Shasun Pharmaceuticals.
or the investors who are holding the stock should continue to hold it but fresh entry should be made only if it corrects from the current levels, says Surajit Pal, pharma analyst at Prabhudas Lilladher.
Gautam Trivedi, MD & CEO of Religare Capital Markets is of the view that one may focus on midcap pharma space.
According to Anand Tandon of Market Expert, the midcap pharma sector will continue to look quite attractive.
Kunal Saraogi, Equityrush advises buying Jain Irrigation for a target price of Rs 83 and Ashok Leyland for a target price of Rs 46.
Market expert, Ambareesh Baliga feels that Shasun Pharmaceuticals may go to Rs 215-220 where one should book out completely.
Kunal Bothra of LKP recommends buying Den Networks with a target of Rs 169 and suggets buying Arvind.
According to Gopi Suvanam, Founder of InvestWorks, one may buy Cipla and Sun Pharmaceutical Industries in the pharma space.
Pritesh Mehta of IIFL advises buying Shasun Pharmaceuticals with a target of Rs 81 and Mahindra and Mahindra (M&M) with a target of Rs 950.
Pritesh Mehta of IIFL suggests buying Shasun Pharmaceuticals with a target of Rs 80 and Cairn India with a target of Rs 340.
According SP Tulsian of sptulsian.com, one should not buy Tata Steel. "One may prefer Idea Cellular, which has corrected today," he adds.
Parag Doctor, Head - Trading Strategies at Keynote Capital's is of the view that one may exit Shasun Pharmaceuticals in current rally.
Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities Limited feels Shasun Pharmaceuticals can move to Rs 92.
Lancelot D Cunha of Sharyans Wealth Management recommends to buy Dewan Housing Finance Corporation with a target price of Rs 164.10 and Shasun Pharma with a target price of Rs 55.80.
Aashish Tater of Fortunewizard.com advises buying Siti with a target price of Rs 22 and Dena Bank with a target price of Rs 74.
Sudarshan Sukhani, s2analytics.com advises to switch from Shasun Pharmaceuticals to Dr Reddy and Cipla.
SP Tulsian, sptulsian.com don‘t think that Dishman Pharma can correct below Rs 84-85. He feels the major correction seems to have got factored in. However, he still feels one should not invest in Dishman Pharma even at current levels.
In CNBC-TV18's popular show Bull's Eye, Pankaj Jain of Sunteck Wealthmax shares trading strategy of the day.